1. Home
  2. LKFN vs PGEN Comparison

LKFN vs PGEN Comparison

Compare LKFN & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakeland Financial Corporation

LKFN

Lakeland Financial Corporation

HOLD

Current Price

$60.00

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.60

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LKFN
PGEN
Founded
1872
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
LKFN
PGEN
Price
$60.00
$3.60
Analyst Decision
Hold
Buy
Analyst Count
3
5
Target Price
$67.00
$8.33
AVG Volume (30 Days)
159.5K
4.2M
Earning Date
04-27-2026
05-13-2026
Dividend Yield
3.49%
N/A
EPS Growth
10.47
N/A
EPS
1.04
N/A
Revenue
$985,000.00
$230,981,000.00
Revenue This Year
$15.50
$1,115.92
Revenue Next Year
$5.51
$81.04
P/E Ratio
$57.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$54.36
$1.38
52 Week High
$69.38
$5.47

Technical Indicators

Market Signals
Indicator
LKFN
PGEN
Relative Strength Index (RSI) 53.19 36.15
Support Level $58.03 $3.49
Resistance Level $60.94 $3.64
Average True Range (ATR) 1.35 0.27
MACD 0.01 -0.08
Stochastic Oscillator 81.49 7.39

Price Performance

Historical Comparison
LKFN
PGEN

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare. The company's revenue is derived from the business of banking.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: